Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prop 65 Steroid Suit Planned Against Supplements Named In Post

This article was originally published in The Tan Sheet

Executive Summary

The Center for Environmental Health plans to file a Prop 65 suit in January against 19 dietary supplement manufacturers and retailers for selling products containing anabolic steroids without warning labels, the group announces in a recent notice letter
Advertisement

Related Content

Bodybuilding.com settlement
Bodybuilding.com settlement
Bodybuilding.com settlement
Are Designer Steroids Dietary Ingredients? FDA Warning Letter Skirts Issue
Are Designer Steroids Dietary Ingredients? FDA Warning Letter Skirts Issue
Ideal AER, Internet Legislation Outlined By CFSAN’s Brackett, FTC’s Peeler
Trade Groups To Rep. Davis: FDA Should Pull Steroids Sold As Supplements
Trade Groups To Rep. Davis: FDA Should Pull Steroids Sold As Supplements
Prop 65 Andro Settlements Include “Corrective Advertising” Provision
Andro Not Within "Anabolic Steroid" Definition, Prop 65 Defendants Say

Topics

Advertisement
UsernamePublicRestriction

Register

PS098901

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel